Publications
Health Care Benefit Grants Notice of Final Rulemaking
Improving Patient-Centered Cancer Care for Medicaid Beneficiaries
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the PA requirements for MAT drug products that are prescribed and dispensed for the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD).
All District of Columbia children eligible for the Medicaid program are entitled to receive the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) services benefit. EPSDT, also known as HealthCheck in DC, is a mandatory Medicaid benefit that includes preventive and specialty care.…
2018 District of Columbia Annual Technical Report (ATR)
The purpose of this transmittal is serve as a final reminder that Program Year 2018 for the DC Medicaid EHR Incentive/Promoting Interoperability Program will close on April 15, 2019.
The purpose of this transmittal is to inform institutional fee-for-service providers of the requirement that an Attending provider NPI is required on all institutional fee-for-service provider claims (UB04/837I).